Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metabolic disturbances are common features of polycystic ovary syndrome (PCOS), which possibly enhance the risk of cardiovascular disease. The aim of this study was to assess the accuracy of lipid accumulation product (LAP) index as a marker of cardiovascular risk in PCOS patients. METHODS: Case-control study including 51 PCOS patients aged between 14 and 35 years and 44 body mass index (BMI) and age-matched controls. Measures included the LAP index, homeostasis model assessment (HOMA) index, glucose tolerance and plasma hormones, cholesterols and triglycerides. RESULTS: LAP index was positively correlated with HOMA index in all subjects (r = 0.70; P < 0.001). Waist circumference (WC) (P = 0.002), HOMA index (P < 0.001) and LAP index (P = 0.035) were higher in PCOS patients than controls. On receiver operating characteristic curve analysis, an LAP index of 34.5 (sensitivity: 84%; specificity 79%) showed a better performance than non-high-density lipoprotein cholesterol, WC or BMI to identify insulin resistance (IR) in all subjects. In PCOS patients, the positive and negative predictive values for LAP > or = 34.5 were 91 and 74%, respectively, compared with 73 and 61%, respectively, for WC > or =80 cm, and 43 and 20%, respectively, for WC > or =88 cm. CONCLUSIONS We have confirmed that IR is more common in PCOS than BMI-matched control women. Furthermore, the LAP index, an easily obtainable measure, is associated with HOMA index and an LAP > or = 34.5 is an additional risk factor for cardiovascular disease in PCOS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · cited 1×
“…cycles (,9 cycles/year), increased levels of serum testosterone and/or free androgen index (FAI), and absence of other disorders causing hirsutism (Spritzer et al., 1990) were enrolled in the study (The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2003; Azziz et al., 2006).”
MethodLegro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970 · cited 2×
“PCOS is also considered a metabolic disorder, since insulin resistance (IR), an independent risk factor for cardiovascular disease, is a common feature in these patients (Dunaif et al., 1987; Ehrmann, 1997; Legro et al., 1999; Wild et al., 2000).”
BackgroundLemieux, I., Pascot, A., Couillard, C., Lamarche, B., Tchernof, A., Alméras, N., Bergeron, J., Gaudet, D., Tremblay, G., Prud’homme, D., et al. (2000) · Circulation · doi:10.1161/01.cir.102.2.179 · Cited by 937
How good a marker is insulin level for insulin resistance?
Laakso, M. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116768 · Cited by 726
Donato, G. B., Fuchs, S. C., Oppermann, K., Bastos, C., & Spritzer, P. M. (2006) · Menopause · doi:10.1097/01.gme.0000177907.32634.ae · Cited by 191 · cited 2×
“…between the lower rib margin and the iliac crest in a plane that is perpendicular to the long axis of the body, with the subject standing balanced on both feet, approximately 20 cm apart, with both arms hanging freely) (World Health Organization, 1995; Donato et al., 2006; Toscani et al., 2007).”
BackgroundResultInfluentialSelf-citationOlefsky, J., Farquhar, J. W., & Reaven, G. (1973) · Diabetes · doi:10.2337/diab.22.7.507 · Cited by 179
Cited by
Spritzer, P. M., Lecke, S. B., Satler, F., & Morsch, D. M. (2015) · Reproduction · doi:10.1530/rep-14-0435 · Cited by 330
“Actually, if PCOS is regarded as a multifactorial disease, it seems reasonable to use calculation tests with good predictive values such as LAP in order to facilitate clinical decision-making (Wiltgen et al. 2009).”
BackgroundResultSelf-citationAdipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome
Dumesic, D. A., Phan, J. D., Leung, K. L., Grogan, T. R., Ding, X., Li, X., Hoyos, L. R., Abbott, D. H., & Chazenbalk, G. D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02086 · Cited by 92
Graff, S. K., Mário, F. M., Alves, B. C., & Spritzer, P. M. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.06.005 · Cited by 79
Self-citationToscani, M. K., Mario, F. M., Radavelli-Bagatini, S., Wiltgen, D., Cristina Matos, M., & Spritzer, P. M. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.564686 · Cited by 52
“Medical interview and physical examination were performed as described [2,15] and included the evaluation of blood pressure and severity of hirsutism [16].”
MethodSelf-citationRamezani Tehrani, F., Minooee, S., & Azizi, F. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0094 · Cited by 51
Toscani, M. K., Mario, F. M., Radavelli-Bagatini, S., & Spritzer, P. M. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.01.009 · Cited by 47
“Abdominal obesity is found in most of these women in association with metabolic disturbances [3-5,7,8], whereas insulin resistance may occur independently of body mass index (BMI), with an adverse impact on lipid profile and blood pressure (BP) [8-11].”
BackgroundSelf-citationMario, F. M., Graff, S. K., & Spritzer, P. M. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0570-1 · Cited by 47
Self-citationHuang, X., Wang, Q., Liu, T., Pei, T., Liu, D., Zhu, H., & Huang, W. (2019) · Endocrine · doi:10.1007/s12020-019-01912-1 · Cited by 34
Zhu, X., Li, Y., Jiang, Y., Zhang, J., Duan, R., Liu, L., Liu, C., Xu, X., Yu, L., Wang, Q., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.665406 · Cited by 32
Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome
Lauria, P. B. M., Del Puerto, H. L., Reis, A. M., Candido, A. L., & Reis, F. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2141 · Cited by 23
“The homeostasis model assessment for IR index (HOMA-IR) (25) and the lipid accumulation product (LAP) index (26) were determined.”
MethodLovato, A. D. C., Corgozinho, M. L. M. V., Alves, L. V., Martins, S. R., Duarte, R. C. F., Cardoso, C. N., Silvino, J. P. D. P., Ferreira, C. N., Silva, I. D. F. O., & Mota, A. P. L. (2022) · Research, Society and Development · doi:10.33448/rsd-v11i4.27432 · Cited by 14
“From weight and height measurements, BMI was determined by the ratio of weight to height squared and classified according to existing cutoff points (Wiltgen et al., 2009).”
MethodAltered Visceral Adipose Tissue Predictors and Women’s Health: A Unicenter Study
Moreira, V. C., de Souza Silva, C. M., & da Silva, I. C. R. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095505 · Cited by 3
“Elevated LAP levels have also been observed in women with polycystic ovarian syndrome (POS), correlating with a significant increase in impaired glucose tolerance prevalence and metabolic disorders caused by the syndrome [32,36].”
Background
Metadata
- Authors
- Wiltgen, D., Benedetto, I. G., Mastella, L. S., & Spritzer, P. M.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03-27
- Volume
- 24
- Issue
- 7
- Pages
- 1726-1731
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2131644715
- Cited by
- 140
- References
- 12
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.